We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Heart Map Facilitates Analysis of Cardiac Function

By LabMedica International staff writers
Posted on 04 Dec 2017
Print article
Image: Foreground: Drawing of a cardiac muscle. Background: excerpt from a heart map, an overview of the proteins analyzed for the proteomic map (Photo courtesy of Doll, Kraue, Menzfield, Max Planck Institute of Biochemistry).
Image: Foreground: Drawing of a cardiac muscle. Background: excerpt from a heart map, an overview of the proteins analyzed for the proteomic map (Photo courtesy of Doll, Kraue, Menzfield, Max Planck Institute of Biochemistry).
A team of German heart researchers used high-resolution liquid chromatography–mass spectrometry to generate a spatial and cell-type-resolved proteomic map of the healthy human heart that they have made available as a resource tool for future analyses of normal heart function and disease.

Liquid chromatography–mass spectrometry (LC-MS) is an analytical chemistry technique that combines the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry. Coupled chromatography - MS systems are popular in chemical analysis because the individual capabilities of each technique are enhanced synergistically. While liquid chromatography separates mixtures with multiple components, mass spectrometry provides structural identity of the individual components with high molecular specificity and detection sensitivity. This tandem technique can be used to analyze biochemical, organic, and inorganic compounds commonly found in complex samples.

Investigators at the Max Planck Institute of Biochemistry (Martinsried, Germany) employed this technique to establish the healthy human heart proteome by measuring 16 anatomical regions and three major cardiac cell types. Specifically, they determined the protein profile of cells in all the regions of the heart, such as heart valves, cardiac chambers, and major blood vessels, and they also investigated the protein composition of three different cell types: cardiac fibroblasts, smooth muscle cells, and endothelial cells. Ultimately, from low microgram sample amounts, they quantified over 10,700 proteins.

The investigators reported in the November 13, 2017, online edition of the journal Nature Communications that by combining copy numbers per cell with protein organellar assignments, they were able to build a model of the heart proteome at the subcellular level. Analysis of cardiac fibroblasts identified cellular receptors as potential cell surface markers. Application of the heart map to atrial fibrillation revealed individually distinct mitochondrial dysfunctions.

"Looking at the protein atlas of the human heart, you can see that all healthy hearts work in a very similar manner. We measured similar protein compositions in all the regions with few differences between them," said first author Sophia Doll, graduate student researcher in the department of proteomics and signal transduction at the Max Planck Institute of Biochemistry. "We were also surprised to find that the right and left halves of the heart are similar, despite having quite different functions: the right half pumps oxygen-poor blood to the lungs, while the left half pumps oxygen-rich blood from the lungs to the body."

The heart map is available to researchers at http://maxqb.biochem.mpg.de as a resource to aid analysis of normal and diseased heart function.

Related Links:
Max Planck Institute of Biochemistry

Gold Member
Pharmacogenetics Panel
VeriDose Core Panel v2.0
Verification Panels for Assay Development & QC
Seroconversion Panels
New
HIV Test
Anti-HIV (1/2) Rapid Test Kit
New
Coagulation Analyzer
CS-2400

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.